Wei Deng

机构：Guangzhou University of Chinese Medicine, Peking University, Second Affiliated Hospital of Guangzhou Medical University, Peking University Cancer Hospital, Mianyang Central Hospital, First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou Medical University · ORCID：0000-0003-1778-2013

发表论文 152 篇 · 总被引 2532 次 · h-index 29

代表论文

• Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial (2025 · Nature Communications · 被引 21)
• AURKB targets DHX9 to promote hepatocellular carcinoma progression via PI3K/AKT/mTOR pathway (2024 · Molecular Carcinogenesis · 被引 19)
• Tumor-Derived Exosomal miR-143-3p Induces Macrophage M2 Polarization to Cause Radiation Resistance in Locally Advanced Esophageal Squamous Cell Carcinoma (2024 · International Journal of Molecular Sciences · 被引 15)
• Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial (2025 · Gynecologic Oncology · 被引 9)
• A nanodrug provokes antitumor immune responses via synchronous multicellular regulation for enhanced cancer immunotherapy (2024 · Journal of Colloid and Interface Science · 被引 9)
• Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026) (2025 · Journal of Clinical Oncology · 被引 8)